从部署的美国军事人员中分离出的不动杆菌菌株的易感性。
Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.
作者信息
Hawley Joshua S, Murray Clinton K, Griffith Matthew E, McElmeel M Leticia, Fulcher Letitia C, Hospenthal Duane R, Jorgensen James H
机构信息
Infectious Disease Service (MCHE-MDI-7E), Brooke Army Medical Center, 3851 Roger Brooke Dr., Fort Sam Houston, TX 78234, USA.
出版信息
Antimicrob Agents Chemother. 2007 Jan;51(1):376-8. doi: 10.1128/AAC.00858-06. Epub 2006 Oct 16.
Abstract
The susceptibilities of 142 Acinetobacter baumannii-calcoaceticus complex isolates (95 from wounded U.S. soldiers deployed overseas) to 13 antimicrobial agents were determined by broth microdilution. The most active antimicrobial agents (> or =95% of isolates susceptible) were colistin, polymyxin B, and minocycline.
摘要
通过肉汤微量稀释法测定了142株鲍曼不动杆菌-醋酸钙不动杆菌复合体菌株（95株来自部署在海外的受伤美国士兵）对13种抗菌药物的敏感性。活性最强的抗菌药物（≥95%的菌株敏感）为黏菌素、多黏菌素B和米诺环素。
相似文献
1
Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.
Antimicrob Agents Chemother. 2007 Jan;51(1):376-8. doi: 10.1128/AAC.00858-06. Epub 2006 Oct 16.
2
3
High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea.
J Antimicrob Chemother. 2007 Nov;60(5):1163-7. doi: 10.1093/jac/dkm305. Epub 2007 Aug 29.
4
Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains.
Antimicrob Agents Chemother. 2007 Oct;51(10):3726-30. doi: 10.1128/AAC.01406-06. Epub 2007 Jul 23.
5
In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
J Antimicrob Chemother. 2007 Aug;60(2):421-3. doi: 10.1093/jac/dkm178. Epub 2007 May 31.
6
Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
Diagn Microbiol Infect Dis. 2011 Jul;70(3):380-6. doi: 10.1016/j.diagmicrobio.2011.03.003. Epub 2011 May 10.
7
Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.
Int J Antimicrob Agents. 2004 May;23(5):487-93. doi: 10.1016/j.ijantimicag.2003.09.026.
8
Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018.
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.01154-19. Print 2019 Nov.
9
Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options.
Clin Infect Dis. 2014 Dec 1;59 Suppl 6:S367-73. doi: 10.1093/cid/ciu706.
10
[Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
Mikrobiyol Bul. 2009 Jul;43(3):383-90.
引用本文的文献
1
An Immunoinformatics-Based Multi-Peptide Vaccine Provides Antibody-Mediated Protection Against Infection.
Vaccines (Basel). 2025 Feb 25;13(3):236. doi: 10.3390/vaccines13030236.
2
An Ancient Drug for a Modern Era: Minocycline for the Treatment of Multi-Drug-Resistant Acinetobacter baumannii.
Cureus. 2024 Jun 6;16(6):e61785. doi: 10.7759/cureus.61785. eCollection 2024 Jun.
3
Reintroduction of Legacy Antibiotics in Neonatal Sepsis: The Special Role of Fosfomycin and Colistin.
Antibiotics (Basel). 2024 Apr 5;13(4):333. doi: 10.3390/antibiotics13040333.
4
Insights into protective immunity.
Front Immunol. 2022 Nov 18;13:1070424. doi: 10.3389/fimmu.2022.1070424. eCollection 2022.
5
Multidrug-Resistant and Virulent Organisms Trauma Infections: Trauma Infectious Disease Outcomes Study Initiative.
Mil Med. 2022 May 4;187(Suppl 2):42-51. doi: 10.1093/milmed/usab131.
6
A Molecular Perspective on Colistin and : Mode of Action, Resistance Genetics, and Phenotypic Susceptibility.
Diagnostics (Basel). 2021 Jun 25;11(7):1165. doi: 10.3390/diagnostics11071165.
7
Recent Advances in the Pursuit of an Effective Vaccine.
Pathogens. 2020 Dec 19;9(12):1066. doi: 10.3390/pathogens9121066.
8
Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii.
Virol Sin. 2019 Aug;34(4):347-357. doi: 10.1007/s12250-019-00125-0. Epub 2019 May 15.
9
Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.
J Clin Microbiol. 2019 Mar 28;57(4). doi: 10.1128/JCM.01390-18. Print 2019 Apr.
10
Pharmacodynamics of Minocycline against in a Rat Pneumonia Model.
Antimicrob Agents Chemother. 2019 Jan 29;63(2). doi: 10.1128/AAC.01671-18. Print 2019 Feb.
本文引用的文献
1
Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.
Antimicrob Agents Chemother. 2006 Sep;50(9):2946-50. doi: 10.1128/AAC.00103-06.
2
Acinetobacter skin colonization of US Army Soldiers.
Infect Control Hosp Epidemiol. 2006 Jul;27(7):659-61. doi: 10.1086/506596. Epub 2006 Jun 12.
3
Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.
Clin Infect Dis. 2006 Mar 1;42(5):657-68. doi: 10.1086/499819. Epub 2005 Jan 25.
4
Tigecycline.
Drugs. 2005;65(18):2623-35; discussion 2636-7. doi: 10.2165/00003495-200565180-00008.
5
In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan.
Microb Drug Resist. 2005 Winter;11(4):330-41. doi: 10.1089/mdr.2005.11.330.
6
Treatment of multidrug resistant Acinetobacter.
Curr Opin Infect Dis. 2005 Dec;18(6):502-6. doi: 10.1097/01.qco.0000185985.64759.41.
7
Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004.
MMWR Morb Mortal Wkly Rep. 2004 Nov 19;53(45):1063-6.
8
Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods.
J Clin Microbiol. 2004 Nov;42(11):5102-8. doi: 10.1128/JCM.42.11.5102-5108.2004.
9
Acinetobacter outbreaks, 1977-2000.
Infect Control Hosp Epidemiol. 2003 Apr;24(4):284-95. doi: 10.1086/502205.
10
Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.
Antimicrob Agents Chemother. 2003 May;47(5):1681-8. doi: 10.1128/AAC.47.5.1681-1688.2003.
Zotero 插件